enGene (ENGN) Holdings announced that it has commenced an underwritten public offering of its common shares. All common shares to be sold in the offering will be offered by enGene. Jefferies, Leerink Partners and Wells Fargo Securities are acting as joint book running managers for the proposed offering.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN:
- enGene price target raised to $19 from $18 at Morgan Stanley
- enGene price target raised to $33 from $30 at Oppenheimer
- enGene price target raised to $10 from $4 at UBS
- Cautious Hold Rating for enGene Holdings Amid Competitive Trial Results and Market Uncertainty
- enGene price target raised to $21 from $18 at Citizens JMP